Intestinal failure

Use of teduglutide in adults with short bowel syndrome-associated intestinal failure

Nutr Clin Pract .2023 Jun 9. doi: 10.1002/ncp.11015. Online ahead of print. Loris Pironi, Johane P Allard, Francisca Joly, Parnia Geransar, Elisabeth Genestin, Ulrich-Frank PapePMID: 37294295 DOI: 10.1002/ncp.11015 Abstract Short bowel syndrome (SBS) is a rare gastrointestinal disorder associated with intestinal failure (SBS-IF) and poor health-related outcomes. Patients with SBS-IF are unable to absorb sufficient nutrients or fluids to maintain significantly metabolic […]

Use of teduglutide in adults with short bowel syndrome-associated intestinal failure Weiterlesen »

Long-term results of teduglutide treatment for chronic intestinal failure – Insights from a national, multi-centric patient home-care service program

ORIGINAL ARTICLE| VOLUME 51, P222-230, OCTOBER 2022 Sophie Greif, Sebastian Maasberg, Jan Wehkamp, Elisabeth Blüthner, Frank Tacke, Ulrich-Frank PapeDOI: https://doi.org/10.1016/j.clnesp.2022.08.027 Abstract Background & aims: Teduglutide is a Glucagon-like peptide-2 (GLP-2) agonist indicated for the treatment of patients with parenteral support (PS) dependent short bowel syndrome (SBS) with chronic intestinal failure (cIF). Its application is accompanied by a structured

Long-term results of teduglutide treatment for chronic intestinal failure – Insights from a national, multi-centric patient home-care service program Weiterlesen »

Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel

JPEN J Parenter Enteral Nutr. 2022 Jul;46(5):1107-1118. doi: 10.1002/jpen.2286. Epub 2021 Nov 18. Johannes Reiner, Peggy Berlin, Jascha Held, Johanna Thiery, Jolanta Skarbaliene, Jonathan Griffin, Wayne Russell, Per-Olof Eriksson, Mark Berner-Hansen, Luise Ehlers, Brigitte Vollmar, Robert Jaster, Maria Witte, Georg LamprechtPMID: 34705281 DOI: 10.1002/jpen.2286 Abstract Background: Extensive intestinal resection may lead to short bowel (SB) syndrome, resulting in intestinal insufficiency or intestinal failure (IF). Intestinal insufficiency and IF involve deficiency of the

Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel Weiterlesen »

Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure.

Joly F, Baxter J, Staun M, et al.: Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure. Clin Nutr 2017; 37: 1415–22.PMID: 28701261 DOI: 10.1016/j.clnu.2017.06.016 Abstract Background & aim: Home parenteral nutrition (HPN) is the primary treatment for chronic intestinal failure (IF). Intestinal transplantation (ITx) is indicated when

Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure. Weiterlesen »

The continued rise of paediatric home parenteral nutrition use: Implications for service and the improvement of longitudinal data collection

Clin Nutr. 2015 Dec;34(6):1128-32. doi: 10.1016/j.clnu.2014.11.009. Epub 2014 Nov 20.The continued rise of paediatric home parenteral nutrition use: Implications for service and the improvement of longitudinal data collection Andrew R Barclay, Paul Henderson, Henry Gowen, John Puntis; BIFS collaboratorsPMID: 25476040 DOI: 10.1016/j.clnu.2014.11.009 Abstract Background & aims: Robust data from the United Kingdom (UK) regarding the

The continued rise of paediatric home parenteral nutrition use: Implications for service and the improvement of longitudinal data collection Weiterlesen »

Home Parenteral Nutrition in Adult Patients With Chronic Intestinal Failure: The Evolution Over 4 Decades in a Tertiary Referral Center

JPEN J Parenter Enteral Nutr. 2017 Sep;41(7):1178-1187. doi: 10.1177/0148607116655449. Epub 2016 Jun 20.Home Parenteral Nutrition in Adult Patients With Chronic Intestinal Failure: The Evolution Over 4 Decades in a Tertiary Referral CenterChristopher Filtenborg Brandt, Mark Hvistendahl, Rahim M Naimi, Siri Tribler, Michael Staun, Per Brøbech, Palle Bekker JeppesenPMID: 27323776 DOI: 10.1177/0148607116655449 Abstract Background/aims: In Denmark,

Home Parenteral Nutrition in Adult Patients With Chronic Intestinal Failure: The Evolution Over 4 Decades in a Tertiary Referral Center Weiterlesen »

S3-Guideline of the German Society for Nutritional Medicine (DGEM) in Cooperation with the GESKES, the AKE and the DGVS

Lamprecht G et al. S3-Leitlinie der Deutschen… Aktuel Ernahrungsmed 2014; 39: e57–e71 Andrew R Barclay, Paul Henderson, Henry Gowen, John Puntis; BIFS collaborators G. Lamprecht, U.-F. Pape, M. Witte, A. Pascher, und das DGEM Steering CommitteeISSN: 0341-0501 DOI:10.1055/s-0034-1369922 Abstract Introduction: Enteral and parenteral nutrition are the cornerstone for the therapy of short bowel syndrome and intestinal failure. The underlying anatomic

S3-Guideline of the German Society for Nutritional Medicine (DGEM) in Cooperation with the GESKES, the AKE and the DGVS Weiterlesen »

Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.

Messing B, Crenn P, Beau P, Boutron-Ruault MC, Rambaud JC, Matuchansky C: Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999; 117: 1043–50. PMID: 10535866 DOI: 10.1016/s0016-5085(99)70388-4 Abstract Background & aims: The short bowel syndrome (SBS) may be associated with either transient or permanent intestinal failure, presently treated by parenteral nutrition

Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Weiterlesen »

Nach oben scrollen
WordPress Cookie Plugin von Real Cookie Banner